The continuous glucose monitoring devices market in China has witnessed significant growth in recent times due to the growing cases of diabetes in the country. Continuous glucose monitoring devices help in monitoring blood glucose levels in real-time among people suffering from diabetes. These devices play a pivotal role in managing diabetes by alerting users about high or low blood glucose levels and allowing timely intervention. With diabetes becoming more prevalent in China due to changing lifestyles and dietary patterns, the need for continuous glucose monitoring devices has increased tremendously.

The Chinese continuous glucose monitoring devices market is estimated to be valued at US$ 176.4 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Increasing prevalence of diabetes has been a key growth driver for the China continuous glucose monitoring devices market. As per the International Diabetes Federation's Diabetes Atlas, there were over 140 million adults living with diabetes in China in 2021. It is further estimated that the number of diabetes cases in China will increase to over 200 million by 2045. The surge in the diabetic population and growing awareness about benefits of continuous glucose monitoring in diabetes management have boosted demand for continuous glucose monitoring devices in recent years. Leading manufacturers are also launching innovative products with advanced features, which is expected to further increase adoption of continuous glucose monitoring devices during the forecast period.

SWOT Analysis

Strength: Continuous glucose monitoring devices in China provide real-time glucose monitoring which helps manage diabetes better. It reduces the need for frequent finger pricking.

Weakness: Continuous glucose monitoring devices are more expensive than self-monitoring blood glucose devices. Data accuracy can be a concern for some devices.

Opportunity: Rising prevalence of diabetes in China is increasing demand for continuous glucose monitoring devices. Growing health awareness is encouraging adoption of these devices.

Threats: Limited reimbursement coverage for continuous glucose monitoring devices restricts their usage. Stringent regulatory approvals delay market entry of new players.


Key Takeaways

The China Continuous Glucose Monitoring Devices Market Size is expected to witness high growth over the forecast period of 2023 to 2030. The Chinese continuous glucose monitoring devices market is estimated to be valued at US$ 176.4 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030.

Rapid economic development, lifestyle changes and aging population are driving the increased prevalence of diabetes in China. This increased prevalence is expected to drive the demand for continuous glucose monitoring devices for better diabetes management.
The north China region currently dominates the continuous glucose monitoring devices market in China due to high adoption. However, central and western China are expected to offer lucrative growth opportunities owing to improving access to healthcare facilities in these regions.

Key players: Key players operating in the China continuous glucose monitoring devices market are Cargill Incorporated, Archer Daniels Midland Company (ADM), Bunge Limited, Ingredion Incorporated, Tate & Lyle PLC. These players are focusing on new product launches and partnerships with local companies to strengthen their presence and tap the high growth opportunities in this market.

Get more insights on this topic:

https://insightskies12.blogspot.com/2023/12/the-china-continuous-glucose-monitoring.html